Btl-lbl (Btl Lbl)
Fingolimod Capsule
Product Images NDC 60505-4332
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fingolimod (NDC 60505-4332). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Ctn-lbl (Ctn Lbl)
This is a medication package containing 28 unit-dose capsules of fingolimod hydrochloride, with each capsule containing 0.5 mg of the medication. This package is equivalent to a four-week supply of medication, and the enclosed Medication Guide should be dispensed. The medication must be stored at room temperature between 15°C to 30°C (59°F to 86°F) and protected from moisture.*
Fingolimod Chemical Structure (Fingo 01)
Figure 1 Time To 3-month Confirmed Disability Progression – Study 1 (itt Population) (Fingo 02)
This text shows a graph indicating the percentage of patients with three-month confirmed progression in days after treatment with Fingolimod Capsules 0.5mg and Placebo. The X-axis represents time in days, and the Y-axis represents the percentage of patients. The data for Fingolimod Capsules is not available.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
